Bioengineering with Cannabinoids, The cannabis plant produces a number of cannabinoids that humans could not find in any other crop. Presumably, that’s because cannabis is the only plant that naturally produces cannabinoids.
Science is gradually recognizing the value of cannabis drugs for medical use. Therefore, these agents are now part of several important research series.
However, cannabis is not an ideal working material for modern medicine because plants can contain different concentrations of all their active ingredients. This makes precise and standardized work difficult. For this reason, experts for the future predict that long-term synthesized finished medicinal products will prevail. To way to produce these methods is known as bioengineering.
Microorganisms produce cannabinoids.
For the targeted production of cannabinoids in an industrial scale, cannabis or commercial hemp is grown on a large scale, depending on whether you want to gain the psychoactive tetrahydrocannabinol (THC) or the non-intoxicating cannabidiol (CBD).
Other cannabinoids can be produced in this way. However, the efficiency of the preparation is quite low, depending on the desired active ingredient. Since most of the crop yield consists of other compounds. Genetic modification can today enable the large-scale production of pharmaceutical-grade cannabinoids.
In some genetic engineering, the cannabis plant is replaced by microorganisms. They produce the required cannabinoids virtually to order and without the remaining, unnecessary plant material.
Programming the cannabis plant for the production of certain active ingredients.
Working without a plant is just one area of bioengineering. In other technologies, the cells of the cannabis plant are genetically modified to modify the chemical processes therein. Through improved chemical synthesis, the plant produces more of the desired cannabinoids.
One of the great advantages of this form of bioengineering is that you can also use cannabinoids cannabigerol (CBG) or Cannabichromene (CBC), which naturally produces the plant only in very small concentrations, in large quantities. Apart from that, the method mainly increases the plant’s resistance to pests and environmental pollution.
Patients are unconvinced about synthesizing cannabis in medicine.
Although the benefits of bioengineering on cannabis are obvious, such technologies are finding resistance among the population. And people’s skepticism is not entirely unfounded. If we look at the development of the use of medicinal cannabis and pharmaceutical companies taking a keen interest in cannabis as a medicine it is noticeable that there are some conflicts of interest.
Most patients swear by cannabis buds and attribute them with the best effects for their symptoms. However, associations of pharmacists, doctors and health insurers try to discredit cannabis as Stone Age medicine and banish them from the medical field.
Since the logic dictates that a health care system is based on the healing and health of the patient, it is incomprehensible why not only the interests of the patients are considered here. Unfortunately, as we all know financial interests are in part contrary to patient welfare.
Natural cannabis and bioengineering can complement each other.
Bioengineering with cannabis does not become obsolete. Simply because it recognizes the efficacy and purpose of cannabis flowers in medicine. Many cannabinoids are poorly understood. One day, the targeted production of an active ingredient, which the plant actually produces only in small amounts, could mean healing for many patients.
In addition, such technologies can eventually make substances like CBD so cost-effective that they will be accessible to people with little financial resources. The traditional cultivation of cannabis and hemp, however, has many benefits for humans and the environment. Therefore, should not lose importance. On the contrary, the methods, traditional and modern, should complement each other.